GlassScriptPhysician profile
Joshua A Pengson
NPI 1578925855
$1,948.17
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.15 · 2020: $1,197 · 2021: $550 · 2022: $110.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $481.19 | 2020-2021 | |
| Lilly USA, LLC | $243.24 | 2019-2021 | |
| Advanced Respiratory, INC | $232.78 | 2020-2021 | |
| Abbvie INC. | $224.39 | 2019-2021 | |
| Novo Nordisk INC | $167.32 | 2020-2021 | |
| Baxter Healthcare | $109.77 | 2022 | |
| Merck Sharp & Dohme LLC | $106.53 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $68.79 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.11 | 2020 | |
| Pfizer INC. | $39.95 | 2021 | |
| Sanofi-Aventis U.S. LLC | $32.80 | 2020 | |
| Eisai INC. | $31.69 | 2020-2021 | |
| Allergan, INC. | $26.01 | 2020 | |
| Glaxosmithkline, LLC. | $19.99 | 2021 | |
| Biogen, INC. | $19.12 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $18.22 | 2021 | |
| Scilex Pharmaceuticals INC. | $16.09 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.53 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.27 | 2020 | |
| Arbor Pharmaceuticals, INC. | $15.14 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $11.63 | 2020 | |
| Abbott Laboratories | $11.61 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Pengson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.